OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53Hany A. Omar, Taleb H. Al‐Tel|Frontiers in Pharmacology|2016Cited by 30
Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarinsFatema Hersi, Taleb H. Al‐Tel|Scientific Reports|2020Cited by 28
A Novel Benzopyrane Derivative Targeting Cancer Cell Metabolic and Survival PathwaysDana M. Zaher, Taleb H. Al‐Tel|Cancers|2021Cited by 5
Discovery of Novel Class of Histone Deacetylase Inhibitors as Anticancer AgentsRaafat El‐Awady, Taleb H. Al‐Tel|Research Square|2021Cited by 0